Answers are grounded in this paper and cite their sources.
Shows Anisaxin-2S exhibits antimicrobial activity, indicating its potential as a new antibiotic candidate.
Antimicrobial peptides (AMPs) have emerged as promising alternatives to conventional antibiotics for combating antimicrobial resistance. In this study, the marine-derived peptide Anisaxin-2S was systematically analyzed using bioinformatics approaches to investigate its structural characteristics and potential mechanism of action. Physicochemical properties and structural features were predicted using ProtParam, SOPMA, and Swiss-model, while amphipathicity was evaluated with ProtScale and HeliQuest. Molecular docking was further performed to explore its interaction with filamenting temperature-sensitive protein Z (FtsZ), a key regulator of bacterial cell division. The results showed that Anisaxin-2S is a small cationic peptide with good stability and thermal stability. It predominantly adopts an α-helical structure with distinct amphipathic distribution, facilitating its interaction with bacterial membranes and leading to membrane disruption. Moreover, docking analysis indicated that Anisaxin-2S can stably bind to the active region of FtsZ, with hydrogen bonding contributing to the stability of the complex. These findings suggest that Anisaxin-2S exerts antibacterial activity through a dual mechanism involving membrane disruption and intracellular targeting.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: